secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zoetis Inc. (ZTS)
CIK:        0001555280
Form:       8-K
Filed at:   2025-05-06T23:59:59+00:00
Accession:  0001555280-25-000201
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zoetis Q1 2025 revenue $2.2B (+9% organic), adj EPS $1.48; affirms 6-8% organic growth for FY
--------------------------------------------------------------------------------

- Revenue $2.2B (+1% reported, +9% organic operational); net income $631M, diluted EPS $1.41.
- Adjusted net income $662M, adj diluted EPS $1.48; +6% organic operational growth YoY.
- U.S. segment revenue $1.2B (+6% organic); International $1.0B (+11% organic on operational basis).
- FY25 guidance: revenue $9.425-9.575B (6-8% organic); adj diluted EPS $6.20-6.30, reflecting FX and tariffs.
- Simparica Trio gains U.S. flea tapeworm label; avian influenza vaccine conditional license in U.S./Canada.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1555280/000155528025000201/0001555280-25-000201-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1555280/000155528025000201/zts-20250506.htm
  HTML page:      https://secwatch.observer/filing/0001555280-25-000201

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer